CTRI/2020/10/028472进行中（未招募）未知
Adjunctive Edaravone for Covid Treatment: A Prospective Randomised Control Pilot Study - COVAED
Sparsh Foundation0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Male and female above 18 years till 65 years with moderate COVID Disease
排除标准
- •Patients with pre-existing kidney and liver diseases.
- •Pregnant and lactating women
- •Patients with hyperreactive airway disease and obstructive airway disease.
- •Patients with co-infections.
- •Immunocompromised patients, either by disease condition(HIV-AIDS..etc) or by drugs( immunomodulators..etc)
- •Patients who are declining to give consent
研究者
相似试验
已完成
3 期
Edaravone in COVID-19IRCT20200317046797N6Tabriz University of Medical Sciences30
招募中
2 期
Effect of Edaravone in treatment of ALSAmyotrophic Lateral Sclerosis.Progressive muscular atrophyRestrictive lung disease due to amyotrophic lateral sclerosisRestrictive lung mechanics due to alsG12.21IRCT20190324043105N1Esfahan University of Medical Sciences20
招募中
3 期
Efficacy of Edaravone with Thrombolysis in Acute Ischemic StrokeIRCT20210530051440N1Zanjan University of Medical Sciences244
尚未招募
3 期
Effectivnes of edaravone on ischemic strokeIschemic stroke.Cerebral infarctionIRCT20240224061102N1Yasouj University of Medical Sciences60
已完成
3 期
Effect of antioxidant (Edaravone) in spinal cord injury patientsCTRI/2017/02/007957Rajeshwar Nath Srivastava96